GlassScriptPhysician profile
Jasmine L Roth
NPI 1881185593
$3,293.24
in general payments reported to CMS, 2019-2025
19 companies · $715 in 2025
The $715 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $241 · 2021: $180 · 2022: $701 · 2023: $598 · 2024: $858 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,153 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,152.86 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $841.71 | 2022-2025 | Miebo, Infuse, Xiidra |
| Abbvie INC. | $306.69 | 2023-2024 | Vuity, Lumigan |
| Astellas Pharma US INC | $292.55 | 2023-2024 | Izervay |
| Alcon Vision LLC | $236.24 | 2020-2025 | Eysuvis, Precision 1, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $202.30 | 2020-2025 | |
| Tarsus Pharmaceuticals, INC. | $179.78 | 2025 | Xdemvy |
| Sight Sciences, INC. | $157.16 | 2021-2022 | |
| Allergan, INC. | $137.29 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $132.12 | 2020-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $130.54 | 2020 | |
| Sun Pharmaceutical Industries INC. | $118.52 | 2021-2025 | |
| Dompe US, INC. | $114.36 | 2022-2025 | Oxervate |
| Oyster Point Pharma, INC. | $111.73 | 2022-2024 | Tyrvaya |
| Coopervision INC. | $92.44 | 2022-2024 | Myday Contact Lens, Misight Contact Lens, Onefit Contact Lens |
| Harrow Eye, LLC | $71.77 | 2024-2025 | Vevye |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $50.68 | 2021-2024 | |
| Glaukos Corporation | $49.65 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $46.99 | 2020-2023 | Lipiflow System Activator (Disposable) |
| Thea Pharma INC. | $20.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.